Medicare Enrolled

Dr. Arjang Miremadi, MD

Dermatology · La Jolla, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
7702 IVANHOE AVE, La Jolla, CA 92037
8584561840
In practice since 2006 (19 years)
NPI: 1497849418 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Miremadi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miremadi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Miremadi

Dr. Arjang Miremadi is a dermatology specialist in La Jolla, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Miremadi performed 4,771 Medicare services across 1,881 unique beneficiaries.

Between the years covered by Open Payments, Dr. Miremadi received a total of $1,799 from 19 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Miremadi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 26% volume in CA $1,799 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,771
Medicare services
Top 26% in CA for dermatology
1,881
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~251 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14
This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer.
1,702 $6 $10
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
725 $67 $150
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
524 $1 $10
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
298 $40 $135
Destruction of 15 or more precancerous skin growths
This procedure involves the removal or destruction of fifteen or more precancerous skin lesions. It is performed to treat abnormal skin cells that have the potential to develop into cancer.
232 $135 $295
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
182 $72 $415
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
178 $11 $70
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
174 $30 $320
Microscopic tissue examination
A pathologist examines a tissue sample under a microscope to identify abnormalities or disease.
167 $5 $276
Destruction of skin growths (warts/lesions), 1-14
This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface.
137 $92 $225
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
100 $80 $200
Injection into skin growths, more than 7
A procedure involving the injection of medication into more than seven skin growths.
57 $51 $122
Destruction of skin growth, 15 or more growths 47 $108 $235
Skin graft repair, 10 sq cm or less
A surgical procedure to repair a wound by transferring a small piece of skin to the affected area. The graft covers wounds on the face, neck, hands, feet, or other specified body parts.
42 $486 $855
All potassium hydroxide (koh) preparations 31 $6 $35
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
30 $40 $315
Skin graft repair, 10 sq cm or less
A surgical procedure to repair a wound on the scalp, arms, or legs by transferring a small piece of skin, 10 square centimeters or less, to the affected area.
30 $458 $875
Lidocaine HCl injection for IV infusion, 10 mg
Administration of a 10 mg dose of lidocaine hydrochloride via intravenous infusion.
30 $0 $22
Skin cancer removal, face or mouth area, 0.6-1.0 cm
Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters.
28 $143 $420
Skin graft repair of trunk wound, 10 sq cm or less
This procedure involves repairing a wound on the trunk by transferring a piece of skin to cover the affected area. The graft covers a surface area of 10.0 square centimeters or less.
16 $453 $959
Skin cancer growth removal, 0.6-1.0 cm
This procedure involves the surgical removal of a cancerous skin growth located on the body, arms, or legs. The size of the growth being removed is between 0.6 and 1.0 centimeters.
15 $139 $402
Surgical removal of skin cancer, 1.1-2.0 cm
Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs.
14 $150 $436
Simple drainage of skin abscess
A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing.
12 $68 $91
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
20.4% medium
79.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,799
Total received (2018-2024)
Avg $257/year across 7 years
Top 49% in CA for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
19
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,411 (78.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$388 (21.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$152
2023
$201
2022
$45
2021
$123
2020
$125
2019
$351
2018
$802

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$62
Janssen Biotech, Inc.
$35
Amgen Inc.
$21
ABBVIE INC.
$19
Incyte Corporation
$15
Top 3 companies account for 77.6% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$416
Janssen Biotech, Inc.
$403
LEO Pharma Inc.
$163
Novartis Pharmaceuticals Corporation
$147
Ortho Dermatologics, a division of Bausch Health US, LLC
$108
Promius Pharma LLC
$99
Amgen Inc.
$77
Regeneron Healthcare Solutions, Inc.
$69
ABBVIE INC.
$67
PFIZER INC.
$62
E.R. Squibb & Sons, L.L.C.
$62
Sun Pharmaceutical Industries Inc.
$28
AbbVie Inc.
$19
AbbVie, Inc.
$18
Lilly USA, LLC
$16
Incyte Corporation
$15
Dermavant Sciences, Inc.
$14
DERMIRA, INC.
$11
GENZYME CORPORATION
$4
Top 3 companies account for 54.6% of all-time payments
Associated products mentioned in payments ›
ABSORICA LD · CIBINQO · COSENTYX · Cloderm Cream · DUPIXENT · ENSTILAR · EUCRISA · Enbrel · ILUMYA · OPZELURA · Otezla · REMICADE · SILIQ · SKYRIZI · Skyrizi · Sotyktu · TALTZ · TREMFYA · Tremfya · VTAMA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a dermatology specialist in La Jolla?
Compare dermatologists in the La Jolla area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
255
Per 100K population
7.8
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Miremadi is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Miremadi experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Miremadi performed 1,702 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miremadi receive payments from pharmaceutical companies?
Yes. Dr. Miremadi received a total of $1,799 from 19 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miremadi's costs compare to other dermatologists in La Jolla?
Dr. Miremadi's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miremadi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →